Search, analyze & compare
My selected companies
Adjust valuation method
![]()
Detail of Embecta Corp.
CEO
Mr. Devdatt Kurdikar
Employees
2000
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Market cap
$814M
Company details
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$1.12B
Cost of goods (CoG)
-$375.70M
Gross profit (GP)
$743.20M
Operating expense (OE)
-$574.30M
Research and development (R&D)
-$82.60M
General and administrative (G&A)
-$364.00M
Other (OTH)
-$127.70M
Operating income (OI)
$168.90M
Other income expense (OIE)
-$1.80M
Pretax income (PI)
$56.20M
Tax (TAX)
$13.50M
Net income (NI)
$69.70M
Stock vs Industry average
-
Industry average
Negative values are hidden from the graph.
Dividend yield
3.25%
Trailing annual dividend rate
$0.60
Payout ratio
50.00%
EPS
$1.19
Margin profit
6.23%
52 week low
$10.13
52 week high
$19.33
50-day simple moving average
$14.00
200-day simple moving average
$14.11
Percent held by insiders
0.47%
Percent held by institutions
98.14%
Dividend yield
3.92%
